In mammalian skeletal muscle, neuronal-type NO synthase (nNOS) is found enriched at neuromuscular endplates. Here we demonstrate the colocalization of the nicotinic acetylcholine receptor (nAChR, stained with α-bungarotoxin) and nNOS (stained with a specific antibody) in murine C2C12 myotubes. However, co-immunoprecipitation experiments demonstrated no evidence for a direct protein-protein association between the nAChR and nNOS in C2C12
reduce contractile force (13, 20) and to modulate uptake and metabolism of glucose (9, 34, 45) .
Most of these NO effects have been attributed to constitutive, Ca 2+ -dependent NO synthase (NOS) activity. In 1993, Nakane et al. (28) reported that mRNA and protein of the neuronaltype NOS (nNOS) is expressed at high levels in skeletal muscle. Further studies showed that in skeletal muscle, nNOS is almost exclusively associated with the sarcolemma and concentrated at neuromuscular endplates (3, 13, 21, 31) . The submembraneous localization of nNOS in skeletal muscle has been attributed to an N-terminal PDZ protein interaction motif, linking nNOS to the dystrophin-glycoprotein complex (DGC) of the extrajunctional sarcolemma (2, 3, 18) . Additionally, nNOS has been shown to directly interact with muscle-specific caveolin 3 (41) that is also a member of the DGC (26, 40) . However, the molecular basis for the accumulation of nNOS protein at neuromuscular endplates is still not completely clear.
Therefore, one aim of this study was to investigate whether nNOS and the nicotinic acetylcholine receptor (nAChR) are linked by a direct protein-protein interaction.
There are disease states that are associated with a significant downregulation of nNOS. For example, in autoimmune myasthenia gravis, nNOS as well as utrophin are markedly reduced at the NMJ (19, 39, 44) . In addition, the disease goes along with a marked loss of membrane nAChRs (11). Whether these phenomena are related is not known at this time. Therefore, the current study also investigates whether a downregulation of the expression of nNOS at the NMJ is associated with a similar regulation of the nAChR.
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Cell culture
C2C12 myoblasts are a subclone of the myogenic C2 cell line derived from regenerating skeletal muscle of adult C3H mice (43) , and can be differentiated into spontaneously contracting myotubes under low-mitogen conditions (38). C2C12 myoblasts were obtained from the American Type Culture Collection (Rockville, MD), and grown under subconfluent conditions (~70% confluence) in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, penicillin and streptomycin at 37°C in a humidified air atmosphere with 10% CO 2 . For differentiation into myotubes, myoblasts (up to passage 10) were allowed to grow to confluence. Then the growth medium was replaced by low-mitogen medium (DMEM, supplemented with 3% horse serum, Invitrogen). The first fused cells were observed 24 to 36 h later. Treatment of cells with LPS (2 µg/ml) and/or IFNγ (100 units/ml) was performed on day 4 of differentiation, when the culture consisted mainly of multinucleated spontaneously contracting myotubes. The mRNA of nNOS and subunits of the nAChR was determined 10 h later, protein was determined 20 h later. Initial time-course studies had indicated that the changes were most apparent at these points in time.
Double-fluorescence labeling of cells
C2C12 cells were cultured on multitest glass slides (Bibby Dunn, Asbach, Germany) coated with a solution of 0.0025% calf skin collagen and 0.005% gelatin (both Merck Eurolab, Darmstadt, Germany) in phosphate-buffered saline (PBS; incubation time ≥ 3 h). All subsequent incubations were carried out in the dark. Unfixed cells were first incubated with
Texas Red-conjugated α-bungarotoxin (Molecular Probes, Leiden, The Netherlands; 1 µg/ml 
Animals and tissues
Male SPF Balb/c mice were obtained from Charles River (Sulzfeld, Germany). Some animals were treated with an intraperitoneal injection of 7.5 mg/kg LPS, dissolved in PBS; control animals received PBS alone. Animals were killed 6 h later by cervical dislocation, and brain and muscle tissues were rapidly removed and frozen in liquid nitrogen.
Cloning of mouse-specific cDNA fragments and generation of antisense RNA Total RNA was isolated either by guanidinium isothiocyanate (GIT)/phenol/chloroform extraction (for cultured cells) (5) or by centrifugation through cesium chloride (for tissues) (35) . Total RNA was isolated from murine cerebellum (for nNOS), murine RAW 264.7 macrophages (for β-actin), C2C12 myotubes (for nAChR α 1 -and γ-subunit), and murine gastrocnemius muscle (for nAChR ε-subunit). 
Ribonuclease protection analyses with mouse-specific cRNA probes
RNase protection analyses were performed as described (35) . Briefly, radiolabeled cRNA probes were generated by in vitro transcription of 0.5 µg plasmid DNA using T3 or T7 RNA 
Immunoprecipitation studies
For immunoprecipitation (IP), 1 ml aliquots of RIPA buffer-solubilized homogenates were precleared by incubation with 50 µl normal rabbit serum (1 h on ice on a rotating shaker). In double-fluorescence studies on C2C12 myotubes, nNOS was found concentrated in areas that also showed a strong labeling for α-bungarotoxin, identifying them as accumulations of nAChRs (Fig. 1) .
No evidence for a direct protein-protein interaction between nNOS and the nAChR α α α α 1 subunit in C2C12 myotubes
In immunoprecipitation experiments with a precipitating antibody specific to the nAChR α 1 -subunit, the α-subunit of the nAChR was detected by Western blots in all precipitates ( Fig. 2A) . However, when an anti-nNOS antibody was used for the immunoprecipitation, no band corresponding to the nAChR α 1 -subunit could be detected ( Fig. 2A) . Conversely, with an anti-nNOS antibody, nNOS protein could be precipitated and detected in subsequent Western blots, whereas no band was found, when the blots were probed with an antibody to the nAChR α 1 subunit (n = 5, not shown). When an anti-utrophin antibody was used for precipitation, neither nNOS nor the nAChR α 1 -subunit could be detected in subsequent
Western blots (n = 4, not shown). However, the anti-utrophin antibody detected a single band of 400 kDa in Western blots with C2C12 cell protein (n = 2, not shown). When the precipitating antibodies were replaced with mouse or rabbit IgG, no specific band could be detected in subsequent Western blots with either an anti-nNOS antibody or an anti-nAChR α 1 antibody (Fig. 2B ).
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Expression of nNOS mRNA and mRNA for nAChR subunits in murine skeletal muscle and C2C12 myotubes: effect of LPS or LPS/IFNγ γ γ γ nNOS mRNA is significantly expressed in diaphragm and gastrocnemius muscle of untreated mice (Fig. 3A) , and also in untreated C2C12 myotubes (Fig. 3B) . The expression of nNOS mRNA was strongly reduced in skeletal muscle after treatment of the mice with LPS (7.5 mg/kg; Figs. 3A), and in C2C12 myotubes treated with LPS (2 µg/ml) and IFNγ (100 units/ml) (Figs. 3B) . Densitometric quantification of this downregulation revealed a decrease of nNOS mRNA to 45 ± 10 % in diaphragm (as compared to controls), to 51 ± 9 % in gastrocnemius muscle, and to 30 ± 3 % in C2C12 myotubes (means ± SEM, n = 6). In contrast, treatment of mice with LPS, or treatment of C2C12 myotubes with LPS/IFNγ did not change the expression of the α-, γ-or ε-subunits of the nAChR (n = 4 to 6, Fig. 4 ). In agreement with the literature (10), the γ-subunit was not found in adult tissue (data not shown).
Protein expression of nNOS and the nAChR in C2C12 myotubes: effect o f LPS/IFNγ γ γ γ
When C2C12 myotubes were treated with LPS (2 µg/ml) and IFNγ (100 units/ml), nNOS immunoreactivity was markedly downregulated (Fig. 5 ). In contrast, there was no apparent change in the expression level of nAChRs (Fig. 5 ). Western blots with protein preparation from untreated and LPS/IFNγ-treated C2C12 myotubes also demonstrated a marked downregulation of nNOS protein to 39% ± 6% of control (n = 4, Fig. 6A ), whereas no significant change was seen for the nAChR α 1 -subunit after LPS/IFNγ treatment (97% ± 5%,
Figs. 6B). Also in skeletal muscle of LPS-treated mice (LPS 7.5 mg/kg), nNOS protein expression decreased significantly; in diaphragm it reached 42% ± 5% of control (mean ± SEM of 3 independent Western blots).
Colocalization, but not coregulation of nNOS and the nAChR Page 12 DISCUSSION nNOS has been found enriched at the postjunctional site of the neuromuscular endplate in slowand fast-twitch fibers of skeletal muscle from different species (4, 13, 44) . In C2C12 skeletal myotubes, nNOS has been shown to cocluster with nAChRs after treatment with active agrin constructs (24) . In the current study, we found nNOS concentrated in the vicinity of nAChR clusters (even in the absence of agrin, Fig. 1 ). Sarcolemmal localization of nNOS has been attributed to an association with dystrophin via PDZ domain-mediated binding to α 1 -syntrophin (2) . However, at the NMJ, dystrophin is almost absent from the crests of the postjunctional folds, i.e. the site where nAChRs accumulate (6, 37) . In these specialized regions, dystrophin is replaced by its homologue utrophin (30) . Utrophin can associate with the nAChR and may be involved in the stabilization of the synaptic cytoskeleton (1, 17) . Unlike dystrophin, utrophin has been found to interact with β 1 -and β 2 -syntrophins, the latter also being largely restricted to NMJs (32) . Hence, β-syntrophins could link nNOS to nAChRs at the NMJ. However, in coimmunoprecipitation experiments, we found no direct protein-protein interactions of nNOS with the nAChR α 1 -subunit in myotubes and also in murine skeletal muscle (Fig. 2) . This failure is unlikely to be technical in nature, because the protein directly immunoprecipitated could always be detected in subsequent Western blots (cf. Fig. 2, lanes 2 and 3) . Furthermore, our laboratory has successfully performed co-immunoprecipitations between iNOS and caveolin-3 (14). We have also been able to co-immunoprecipitate nNOS and caveolin-3 from mouse skeletal muscle (unpublished results), thereby confirming findings of others (41).
However, attempts to coprecipitate the nAChR α 1 -subunit with an anti-utrophin antibody were also unsuccessful. Thus, the molecular basis of the regional association of the nAChR with nNOS (shown in Figs.1 ) remains unclear at this time.
Functionally, the colocalization of nNOS and the nAChR may favor potential effects of NO on acetylcholine release. Lindgren and Laird (23) have shown that NO inhibits the evoked release Ebert et al.
Colocalization, but not coregulation of nNOS and the nAChR Page 13 of neurotransmitter at the frog neuromuscular junction. On the other hand, inhibitors of NOS activity increased acetylcholine release at the motor nerve terminals (33) . Thus, NO produced locally by nNOS may be involved in the physiological modulation of ACh release. Local NO may also modulate the sensitivity of the nAChR or interfere with subsequent signal transduction cascades. Conversely, activation of nAChR has been shown to activate a Ca 2+ -dependent protein kinase C pathway that, in turn, upregulates nNOS mRNA expression (27) . Also such signaling could be promoted by a close proximity of the nAChR and the nNOS.
We have reported previously that nNOS is downregulated in skeletal muscle of guinea pigs treated with LPS (15) . The present study confirms this finding for murine skeletal muscle and shows a similar downregulation of nNOS in murine C2C12 myotubes following treatment with LPS and IFNγ (Figs. 3, 5 and 6 ).
In certain disease states such as autoimmune myasthenia gravis, the expression of nNOS as well as utrophin is markedly reduced at the NMJ (19, 39, 44) . In parallel there is a loss of membrane nAChRs (11). However, in the current study, the LPS/IFNγ-induced reduction in nNOS expression was not accompanied by a similar downregulation of the nAChR (Figs. 4 to   6 ). This suggests, that although the two proteins are located in close proximity, their expression is regulated independently. Also in skeletal muscle from mdx mice, a dystrophindeficient animal model for Duchenne muscular dystrophy, nNOS and syntrophins are strongly reduced or completely absent from the extrajunctional sarcolemma (2, 3, 32) and the NMJ (4, 16, 44) , whereas the nAChRs have been reported normal in number and localization at the NMJ of muscles from mdx mice (25) . This situation is similar to the one observed in the current study, where the expression of nNOS was downregulated with no change in the expression of the nAChR. 
